The Hypocrisy In Annual Salaries:

Mylan Pharmaceuticals CEO Heather Bresch defended her company’s pricing of its popular EpiPen during a hearing before a U.S. House Committee today. Beyond the apparent price gouging involved, her annual salary which increased 67 percent to $18.9 million in 2015 was called into question. Hold that thought! Meanwhile across the…

Continue Reading